###begin article-title 0
###xml 43 63 43 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 43 63 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 130 138 <span type="species:ncbi:9606">Patients</span>
Association of Plasma Circulatory Markers, Chlamydia pneumoniae, and High Sensitive C-Reactive Protein in Coronary Artery Disease Patients of India
###end article-title 0
###begin p 1
###xml 22 27 <span type="species:ncbi:157061">Mandi</span>
Recommended by Yvette Mandi
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 239 252 239 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 713 718 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 823 824 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 899 904 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 931 932 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 952 965 944 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 1100 1105 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1126 1127 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1315 1328 1303 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 1371 1377 1359 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 239 252 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 952 965 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 1315 1328 <span type="species:ncbi:83558">C. pneumoniae</span>
Plasma inflammatory markers have been shown to be predictors for cardiovascular risk, however, there is no study where the levels of plasma circulatory markers have been evaluated in coronary artery disease patients (CAD pts) positive for C. pneumoniae IgA and high sensitive C-reactive protein (hsCRP) which may help in better understanding of disease pathogenesis. A total of 192 patients and 192 controls attending the Cardiology Outpatient Department of Safdarjung Hospital were enrolled. The levels of plasma circulatory inflammatory markers were evaluated by ELISA. The levels of circulatory plasma markers (IL-4, IL-8, IL-13, ICAM-1, and VCAM-1) were significantly higher, whereas, levels of IL-10 and IFN-gamma were significantly lower in CAD pts compared to healthy controls. The levels of IL-4, IL-8, and ICAM-1 (P = .007, .015, and .048) were significantly higher, however, IL-10 and IFN-gamma were significantly lower (P < .001, < .001) in C. pneumoniae IgA positive CAD pts. The levels of IL-4, IL-8, IL-13, ICAM-1, and VCAM-1 were higher but not significant and levels of IL-10 and IFN-gamma were significantly (P < .001, < .001) lower in hsCRP positive CAD pts. Our study suggested that circulatory cytokines, namely, IL-4, IL-8, and adhesive molecules like ICAM-1 were enhanced after infection with C. pneumoniae whereas in contrast to this IL-10 and IFN-lambda were lowered. Suggesting the important role of these cytokines in progression of CAD.
###end p 3
###begin title 4
1. Introduction
###end title 4
###begin p 5
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 380 400 380 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 402 415 402 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 745 746 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1312 1314 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1401 1403 1401 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1461 1474 1461 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 1505 1507 1505 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1593 1606 1593 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 1910 1923 1910 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 380 400 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 402 415 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 1461 1474 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 1495 1503 <span type="species:ncbi:9606">patients</span>
###xml 1593 1606 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 1653 1661 <span type="species:ncbi:9606">patients</span>
###xml 1844 1852 <span type="species:ncbi:9606">patients</span>
###xml 1910 1923 <span type="species:ncbi:83558">C. pneumoniae</span>
Atherosclerosis is an inflammatory disease which may be the outcome of responses to microbial antigens [1, 2]. Several conserved components of the bacterial cell wall have been shown to bind to receptors on the cell surface of monocyte and macrophages which may induce production of proinflammatory cytokines [3]. The role of chronic low-grade infection of the arterial wall with Chlamydia pneumoniae (C. pneumoniae) in the pathogenesis of atherosclerosis has been suggested in a series of epidemiological and pathological studies and may induce innate immunity, molecular mimicry, and autoimmunity as well as direct infection of tissues [4-8]. Earlier prospective studies have shown CRP to be a strong independent predictor of coronary events [1]. It seems that the macrophages deactivating cytokines IL-4 and IL-13 display proinflammatory activities in the vascular system [9] and that IL-8 may have a role as a leukocyte chemoattractant during atherogenesis [10]. Intercellular adhesion molecule-1 (ICAM-1), a major adhesion receptor expressed on the endothelium, is involved in monocyte adhesion to endothelial cells [11]. The vascular adhesion molecule (VCAM-1) has been reported to bind particularly to those classes of leukocytes found in nascent atheroma consisting of the monocyte and the T lymphocyte [12]. Thus, proinflammatory cytokines may link hypercholesterolemia to VCAM-1 expression [13]. We reported earlier association of hsCRP and IL-6 with C. pneumoniae IgA serology in CAD patients [14, 15], however, there is no study where levels of these plasma circulatory markers in C. pneumoniae IgA positive and hsCRP positive groups of CAD patients have been evaluated which is required for understanding pathogenesis of CAD. Hence the aim of this study was to perceive the levels of plasma circulatory inflammatory markers in CAD patients in the presence of well established CAD markers, namely, C. pneumoniae IgA and hsCRP in Indian population.
###end p 5
###begin title 6
2. Materials and Methods
###end title 6
###begin title 7
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients
###end title 7
###begin p 8
###xml 15 23 <span type="species:ncbi:9606">patients</span>
A total of 192 patients (148 males and 44 females) attending the Cardiology Outpatient Department of Safdarjung hospital from March 2005 to June 2007 for angiographically confirmed CAD were enrolled for the study after prior written consent. In addition, 192 age and sex matched healthy controls with no evidence of CAD (142 males and 50 females) were also included in the study. The study received clearance from the hospital ethics review committee.
###end p 8
###begin title 9
2.2. Inclusion Criteria
###end title 9
###begin p 10
Evidence of CAD required at least one of the following: (1) significant stenosis (70% of luminal diameter) in at least one major coronary artery proved by angiography and had undertaken either percutaneous coronary intervention or coronary artery bypass graft (CABG); (2) positive stress myocardial perfusion imaging studies for ischemia.
###end p 10
###begin title 11
2.3. Exclusion Criteria
###end title 11
###begin p 12
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients were not included if any of the following was present myocardial infarction or CABG in the preceding 3 months, unstable angina, significant valvular heart disease, blood pressure 180/100 mm.
###end p 12
###begin title 13
2.4. Collection of Samples
###end title 13
###begin p 14
###xml 234 240 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 284 297 273 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 284 297 <span type="species:ncbi:83558">C. pneumoniae</span>
Venous blood (5 mL) was collected in nonheparinized tubes from CAD patients and controls. Serum was separated within 2 hours of blood collection and kept at -80degreesC until used for detection of hsCRP, IL-4, IL-8, IL-10, IL-13, IFN-lambda, ICAM-1 and VCAM-1, and antibodies against C. pneumoniae IgA.
###end p 14
###begin title 15
2.5. Serology and Antibody Level of Atherosclerotic Marker
###end title 15
###begin p 16
###xml 28 41 28 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 472 478 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 28 41 <span type="species:ncbi:83558">C. pneumoniae</span>
Detection of antibodies for C. pneumoniae specific IgA was performed using commercially available ELISA kit (R-Biopharm AG, Germany), as mentioned earlier [8]. For detection of antibodies to hsCRP, ELISA was performed using kits (Calibiotech Inc., Calif, USA) as per manufacturer's instructions and level of the hsCRP (>3 mg/L) in serum was considered as hsCRP positive in dichotomized result. Detection of concentration of interleukins (IL-4, IL-8, IL-10, IL-13, and IFN-lambda), adhesive molecules (ICAM-1 and VCAM-1) was performed using commercially available ELISA kit (e-biosciences, San Diego, Calif, USA) and (Diaclone, France) as, respectively, manufacturer's instructions. Sensitivity and specificity for all kits used in the study were >95%.
###end p 16
###begin title 17
2.6. Statistical Analysis
###end title 17
###begin p 18
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 118 121 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 135 141 <span type="species:ncbi:76720">fisher</span>
Differences between two groups were evaluated using Mann-Whitney U-test. For comparing binary related characteristics chi-square test, fisher-exact statistic was used. Simultaneously, an alpha level of 0.05 was set as the level of significance.
###end p 18
###begin title 19
3. Results
###end title 19
###begin title 20
###xml 27 35 <span type="species:ncbi:9606">Patients</span>
3.1. Classification of CAD Patients and Controls on the Basis of Age and Sex
###end title 20
###begin p 21
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
Three age groups of CAD patients and controls were included in this study, however, none of the groups were found to be significantly different. Males and females were also not found to be significantly different when CAD patients and controls were compared (Table 1).
###end p 21
###begin title 22
3.2. Evaluation of Plasma Circulatory Markers in CAD pts and Controls
###end title 22
###begin p 23
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 182 188 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 221 222 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 274 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
Levels of plasma circulatory markers viz IL-4, IL-8, IL-13, ICAM-1 and VCAM-1 were significantly higher (P < .001, <.001, .004, <.001, <.001) in contrast to, levels of IL-10 and IFN-lambda which were significantly lower (P < .001) in CAD pts as compared to controls (Table 2).
###end p 23
###begin title 24
3.3. Evaluation of Plasma Circulatory Markers in C. Pneumoniae IgA Positive CAD pts and Controls
###end title 24
###begin p 25
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 121 108 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 158 171 158 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 230 236 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 263 264 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 328 329 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 346 352 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 378 379 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 391 404 381 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 442 455 432 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 479 486 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 108 121 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 158 171 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 391 404 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 442 455 <span type="species:ncbi:83558">C. pneumoniae</span>
Mean levels of IL-4, IL-8, and ICAM-1 were significantly higher (P = .007, .015, <.001, <.001, and .048) in C. pneumoniae IgA positive CAD pts as compared to C. pneumoniae IgA negative CAD pts, whereas the levels of IL-10 and IFN-lambda were significantly lower (P < .001, <.001). Mean levels of IL-4 were significantly higher (P < .001) and IFN-lambda was significantly lower (P = .006) in C. pneumoniae IgA positive controls as compared to C. pneumoniae IgA negative controls (Table 3).
###end p 25
###begin title 26
3.4. Evaluation of Plasma Circulatory Markers in hsCRP Positive CAD pts and Controls
###end title 26
###begin p 27
###xml 142 148 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 175 176 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 358 365 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
Mean levels of plasma circulatory markers IL-4, IL-8, IL-13, ICAM-1, and VCAM-1 were higher but not significant while levels of IL-10 and IFN-lambda were significantly lower (P < .001) in hsCRP positive CAD pts as compared to hsCRP negative CAD pts. Additionally, similar results were found in hsCRP positive controls as compared to hsCRP negative controls (Table 4).
###end p 27
###begin title 28
4. Discussion
###end title 28
###begin p 29
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 258 271 258 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 328 333 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 376 377 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 379 381 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 552 554 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 775 788 771 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 813 815 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 817 819 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 927 933 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 948 961 939 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 983 996 974 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 1335 1337 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1339 1341 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1470 1472 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1696 1698 1687 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1924 1926 1915 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 2003 2008 1994 1995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 2052 2054 2039 2041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 2202 2215 2189 2202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 2379 2381 2366 2368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 2405 2407 2392 2394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 258 271 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
###xml 775 788 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 948 961 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 983 996 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 1010 1018 <span type="species:ncbi:9606">patients</span>
###xml 1176 1184 <span type="species:ncbi:9606">patients</span>
###xml 2141 2149 <span type="species:ncbi:9606">patients</span>
###xml 2202 2215 <span type="species:ncbi:83558">C. pneumoniae</span>
A variety of plasma inflammatory markers have been shown to predict future cardiovascular risk [16] and is useful for risk stratification and also for identifying those patients who may benefit from targeted interventional therapy. It has been reported that C. pneumoniae induces much more IL-6 and IL-8 and lower levels of IFN-gamma compared to other Gram-positive bacteria [3, 17]. The induction of monocyte procoagulant activity with either IL-6 or IL-8 has been proposed as a possible link between inflammation and thrombosis in patients with CAD [18]. IL-8 has also been reported to play a minor role in mediating monocyte recruitment and adhesion associated with neutrophil chemotaxis [19]. Increased expression of cell adhesion molecules in response to infection with C. pneumoniae has also been reported [20, 21]. In our study levels of cytokines IL-4, IL-8, and ICAM-1 were detected higher and levels of IL-10 and IFN-lambda were lower in C. pneumoniae positive compared to C. pneumoniae negative CAD patients. Moreover, levels of IL-4, IL-8, IL-13, ICAM-1, and VCAM-1 were detected higher but not significant in hsCRP positive CAD pts compared to hsCRP negative CAD patients. It has been earlier reported that CRP clearly enhances IL-8 production at 8 to 24 hours of incubation, although a considerably less potent than CRP [22, 23]. However, Gabay et al. showed that IL-4 and IL-13 decreased the levels of CRP in primary hepatocytes and hepatoma hepG2 cells [24]. Kieda et al. reported that leukocyte recruitment to the endothelium is mediated by the interaction of adhesion molecule receptors expressed on the surface of endothelium cells for effective host defense against bacteria [25]. Also it is reported that very late antigen-4 (VLA-4), a major adhesion receptor is expressed by T lymphocytes, mediates T-cell adhesion in the microvasculature via an interaction with VCAM-1 on activated endothelial cells [26]. Kawanami et al. showed that CRP induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells [27], which is parallel to our findings where elevated hsCRP was detected in serum of CAD patients. In our study among different age groups, levels of C. pneumoniae IgA were not significantly different (data not shown). Similar results were reported by Masato et al. whereas it is contradictory to that reported by Hahn et al. [28] and Nishimura et al. [29].
###end p 29
###begin title 30
5. Conclusion
###end title 30
###begin p 31
###xml 155 168 155 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pneumoniae</italic>
###xml 211 217 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</italic>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 155 168 <span type="species:ncbi:83558">C. pneumoniae</span>
Overall, our study suggested that circulatory cytokines, namely, IL-4, IL-8 and adhesive molecules like ICAM-1 were enhanced in CAD patients infected with C. pneumoniae whereas in contrast to this IL-10 and IFN-lambda were lowered. Additionally, these cytokines were also enhanced in hsCRP positive CAD-pts, suggesting the important role of these cytokines in progression of CAD.
###end p 31
###begin title 32
Acknowledgments
###end title 32
###begin p 33
The authors wish to thank Mr. Yogendra Kumar and Mrs Madhu Badhwar for providing technical assistance. Indian Council of Medical Research (ICMR) is acknowledged for providing financial assistance to Hem Chandra Jha and Pragya Srivastava in the form of fellowship. The study was funded by Department of Science and Technology, SR/SO/HS-6/2005, India.
###end p 33
###begin article-title 34
Atherosclerosis in ANCA-associated vasculitides
###end article-title 34
###begin article-title 35
T cell mimicry in inflammatory heart disease
###end article-title 35
###begin article-title 36
###xml 100 105 <span type="species:ncbi:9606">human</span>
Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes
###end article-title 36
###begin article-title 37
###xml 24 44 24 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 24 44 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
###end article-title 37
###begin article-title 38
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 0 20 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Chlamydia pneumoniae and atherosclerosis: the end?
###end article-title 38
###begin article-title 39
The role of Chlamydia in coronary heart disease-fact or fiction?
###end article-title 39
###begin article-title 40
###xml 12 32 12 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 12 32 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran
###end article-title 40
###begin article-title 41
###xml 52 72 52 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 52 72 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern
###end article-title 41
###begin article-title 42
Signaling mechanisms, interaction partners, and target genes of STAT6
###end article-title 42
###begin article-title 43
Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective
###end article-title 43
###begin article-title 44
###xml 83 89 <span type="species:ncbi:10090">murine</span>
Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis
###end article-title 44
###begin article-title 45
Inflammation in atherosclerosis
###end article-title 45
###begin article-title 46
###xml 143 150 <span type="species:ncbi:9986">rabbits</span>
VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits-a potential role in vein graft atherosclerosis
###end article-title 46
###begin article-title 47
###xml 50 70 50 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 72 91 72 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 50 70 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 72 91 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker
###end article-title 47
###begin article-title 48
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 0 20 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease
###end article-title 48
###begin article-title 49
Cytokines in atherosclerosis: pathogenic and regulatory pathways
###end article-title 49
###begin article-title 50
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies
###end article-title 50
###begin article-title 51
Leukocytes and coronary heart disease
###end article-title 51
###begin article-title 52
Glucose regulates monocyte adhesion through endothelial production of interleukin-8
###end article-title 52
###begin article-title 53
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydophila pneumoniae</italic>
###xml 145 150 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 0 24 <span type="species:ncbi:83558">Chlamydophila pneumoniae</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB
###end article-title 53
###begin article-title 54
###xml 67 87 67 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 67 87 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Expression of adhesion molecules on endothelial cell stimulated by Chlamydia pneumoniae
###end article-title 54
###begin article-title 55
###xml 117 122 <span type="species:ncbi:9606">human</span>
Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils
###end article-title 55
###begin article-title 56
###xml 94 99 <span type="species:ncbi:9606">human</span>
Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells
###end article-title 56
###begin article-title 57
###xml 107 112 <span type="species:ncbi:9606">human</span>
Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production
###end article-title 57
###begin article-title 58
Endothelial adhesion molecules contribution to leukocyte recruitment into inflamed tissues
###end article-title 58
###begin article-title 59
###xml 83 88 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-alpha production and neutrophil adhesion: role of very late antigen-4/vascular cell adhesion molecule-1
###end article-title 59
###begin article-title 60
###xml 61 66 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells
###end article-title 60
###begin article-title 61
###xml 15 35 15 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 15 35 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma
###end article-title 61
###begin article-title 62
###xml 21 41 21 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 21 41 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients
###end article-title 62
###begin p 63
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Characteristics of coronary artery disease patients and controls.
###end p 63
###begin p 64
Figure in parenthesis indicates % positivity.
###end p 64
###begin p 65
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Evaluation of plasma circulatory markers in coronary artery disease patients and controls.
###end p 65
###begin p 66
CAD: coronary artery disease; *: significant; SD: standard deviation; IL: interleukin; ng: nanogram; pg: pikogram; mL: mililiter; IFN: interferon; ICAM: intercellular adhesion molecule; VCAM: vascular adhesion molecule.
###end p 66
###begin p 67
###xml 44 64 44 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae</italic>
###xml 44 64 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Evaluation of plasma circulatory markers in Chlamydia pneumoniae IgA positive coronary artery disease patients and controls.
###end p 67
###begin p 68
CAD: coronary artery disease; *: significant; SD: standard deviation; IL: interleukin; ng: nanogram; pg: pikogram; mL: mililiter; IFN: interferon; ICAM: Intercellular adhesion molecule; VCAM: vascular adhesion molecule; IgA: immunoglobulin A; +ve: positive; -ve: negative.
###end p 68
###begin p 69
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Evaluation of plasma circulatory markers in high-sensitive C-reactive protein positive coronary artery disease patients and controls.
###end p 69
###begin p 70
CAD: coronary artery disease; *: significant; SD: standard deviation; IL: interleukin; ng: nanogram; pg: pikogram; mL: mililiter; IFN: interferon; ICAM: intercellular adhesion molecule; VCAM: vascular adhesion molecule; hsCRP: high-sensitive C-reactive protein; +ve: positive; -ve: negative.
###end p 70

